[研究报告] 生理盐水市场规模预计将从 2022 年的 55.2217 亿美元增长到 2030 年的 90.5704 亿美元。预计 2022 年至 2030 年市场复合年增长率为 6.4%。
分析师观点
生理盐水市场分析解释了增长驱动因素,例如严重疾病和液体电解质紊乱患病率上升,以及老年人对液体电解质的需求激增。此外,预计医院环境中大规模盐溶液需求将成为 2022-2030 年市场的新趋势。按类型划分,生理盐水市场分为普通盐水、高渗盐水、低渗盐水和平衡盐水。普通盐水部分在 2022 年占据最大市场份额。然而,预计高渗盐水部分在 2022-2030 年期间的复合年增长率最高。按包装类型划分,生理盐水市场分为软袋、塑料瓶和玻璃瓶。塑料瓶部分在 2022 年占据最大市场份额。预计软袋部分在 2022-2030 年期间的复合年增长率最高。按应用划分,生理盐水市场分为静脉注射、眼科、伤口护理、内窥镜检查、皮肤擦伤等。静脉注射部分在 2022 年占据最大市场份额,预计同一部分在 2022-2030 年期间的复合年增长率最高。按给药途径划分,生理盐水市场分为静脉注射和外用。静脉注射部分在 2022 年占据更大的市场份额,预计同一部分在 2022-2030 年期间的复合年增长率更高。按最终用户划分,生理盐水市场分为医院、专科诊所、门诊手术中心、家庭护理等。医院部分在 2022 年占据最大市场份额。预计专科诊所部分在 2022-2030 年期间的复合年增长率最高。
生理盐溶液由等渗且具有相同 pH 值的盐溶液组成。生理盐溶液的一个例子是林格氏溶液,由氯化钠 (NaCl)、碳酸氢钠和氯化钾溶液混合而成。医生建议使用生理溶液来治疗脱水、体液失衡和许多其他类似的临床异常情况。
市场洞察
严重疾病和液体电解质紊乱患病率上升推动生理盐水市场发展
重病患者往往丧失了独立性、时间和能力。除了特定精神疾病引起的身体症状外,重病患者还可能遭受情感、身体和经济上的双重打击,甚至改变其一生。根据联邦基金会报告的统计数据,62%的重病患者会感到焦虑、困惑或无助,48%的人因重病而出现情绪或心理问题,32%的人感到被排斥、缺乏陪伴和与他人隔绝。美国国家卫生委员会的报告显示,近1.33亿美国人患有无法治愈的慢性病,占美国总人口的40%以上。其中,近50%的成年人和近8%的5-17岁儿童患有慢性病。美国国家卫生委员会的报告还提到,美国人中越来越多的无法治愈的慢性病患者造成了约75%的医疗费用。
严重疾病会导致体液失衡,例如体内钾、镁、钙和钠含量低。体液水平不当会对身体功能、肌肉力量和心律产生负面影响,这与肾脏或内分泌腺疾病有关。例如,当身体保留过多的液体水平时会发生水肿,导致患者的面部、手臂、腿部、手和脚肿胀和疼痛。此外,流失的体液多于消耗的量会导致脱水,最终导致患者出现口渴、虚弱、头晕、昏厥和尿量减少等症状。因此,慢性疾病可能导致患者体内体液失衡,从而推动对作为治疗一部分的生理盐水的需求。因此,严重疾病和液体电解质紊乱的患病率上升促进了生理盐水市场的增长。
未来趋势
医院环境中的大规模盐水需求
根据英国皇家化学学会发表的报告,在医院环境中使用生理盐水清洗红细胞 (RBC) 和治疗危重患者是一种常见做法。临床研究小组审查了在不同临床环境中使用生理盐水 (0.9% NaCl) 的安全性,并指出使用生理盐水是医院环境中最安全的技术之一。例如,在输血医学中,在血液分离术和失血或失液患者复苏的情况下,生理盐水用于清洗细胞和抢救程序。清洗红细胞需要 1-2 升无菌生理盐水。在血液分离术中,生理盐水用于治疗性血浆置换程序和术中细胞抢救以清洗红细胞。因此,在医院环境中大规模使用生理盐水的多方面应用可能会成为生理盐水市场的新趋势。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围
基于类型的洞察
生理盐水市场按类型分为普通盐水、高渗盐水、低渗盐水和平衡盐水。普通盐水部分在 2022 年占据最大市场份额;高渗盐水部分预计在 2022-2030 年期间实现最高复合年增长率。生理盐水 (NS) 是一种无菌盐溶液,用于短期补液,有助于恢复体内的电解质/盐水平。它是一种 0.9% 的氯化钠溶液,用于治疗人类脱水和电解质紊乱。NS 是临床环境中常用的静脉注射溶液的基石。它适用于儿科和成人患者群体。美国食品药品监督管理局 (FDA) 批准使用 NS 溶液的主要适应症如下:
- 细胞外液补充,治疗脱水、血容量不足、出血、脓毒症等。
- 体液丢失导致代谢性碱中毒的治疗
- 轻度钠缺乏
此外,生理盐水只能通过静脉途径给药,而生理盐水的管理需要评估患者的健康状况。药剂师在医院安装时需要监控静脉输液的实施情况。
基于包装类型的见解
生理盐水市场按包装类型分为软袋、塑料瓶和玻璃瓶。塑料瓶部分在 2022 年占据了最大的市场份额。预计软袋部分在 2022-2030 年期间的复合年增长率最高。注射用氯化钠 (NaCl) USP 溶液是无菌和无热原的。它们是肠外溶液,在注射用水 (WFI) 中含有不同浓度的 NaCl,用于静脉 (IV) 给药。此外,软容器由特殊配制的聚氯乙烯制成。然而,储存在塑料容器中的溶液可能会引发塑料中某些化学成分的微量浸出。尽管如此,塑料容器材料的安全性可以通过生物评估方法有效测试。预计在预测期内,塑料瓶部分将占生理盐水市场的最小份额。
基于应用的洞察
生理盐水市场按应用细分为静脉注射、眼科、伤口护理、内窥镜检查、皮肤擦伤等。静脉注射部分在 2022 年占据了最大的市场份额。预计在 2022-2030 年期间复合年增长率最高。静脉 (IV) 盐水溶液用于预防或治疗脱水。医生会为受伤、生病、脱水或接受手术的人开静脉注射盐水,无论年龄大小。盐水 IV 袋可快速、有针对性地补充液体并缓解症状。此外,无菌水和氯化钠或盐和生理盐水 IV 的组合有助于恢复患者的体液平衡和滋润组织。当患者需要补水时,静脉注射盐水通常直接注入患者血液中。对于对特定药物过敏或敏感的人来说,它被认为是一种合适的选择。
各家公司都在提供创新的静脉输液盐水产品;例如,Fresenius Kabi USA 提供“freeflex”和“freeflex+ IV 袋”。这些产品还提供防漏、无菌保护和防针刺功能。
基于给药途径的见解
生理盐水市场按给药途径分为静脉注射和局部注射。静脉注射部分在 2022 年占据了最大的市场份额。预计该细分市场的复合年增长率将在 2022-2030 年期间达到最高。静脉注射盐溶液是注入静脉以预防和治疗脱水的特殊配制液体。此外,这些静脉注射液还用于患有疾病、受伤、脱水等疾病的各个年龄段的人。静脉注射盐溶液的给药程序简单安全,并发症风险低。此外,液体复苏是急性病患者管理的重要组成部分,生理盐水被认为是重病或受伤患者最广泛使用的静脉注射液。作为一种常见、简单且安全的程序,通过静脉注射给药的患者可能会在短时间内感到缓解。
生理盐水市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响生理盐水市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的生理盐水市场细分和地理位置。
- 获取生理盐水市场的区域具体数据
生理盐水市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 55.2217亿美元 |
2030 年的市场规模 | 90.5704 亿美元 |
全球复合年增长率(2022 - 2030 年) | 6.4% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
生理盐水市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。
在生理盐水市场运营的主要公司有:
- 费森尤斯卡比公司
- 默克公司
- AdipoGen 生命科学公司
- 恩佐生命科学公司
- ICU医疗公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解生理盐水市场顶级关键参与者概况
区域分析
预计亚太地区在 2022-2030 年期间将在全球生理盐水市场中实现最高的复合年增长率。亚太地区的市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。中国在亚太地区的生理盐水市场中占有最大的份额。2020-2030 年中国生理盐水市场的增长归因于慢性病发病率的上升。根据中华人民共和国国家卫生委员会的数据,已有超过 3 亿患者被诊断出患有慢性病,占慢性病死亡总数的 86.6%。中国还报告了第二多的结核病 (TB) 病例数。根据美国疾病控制和预防中心 (CDC) 公布的统计数据,2020 年,中国有近 842,000 人被诊断出患有结核病。同样,患者中的慢性病也导致对生理盐水的需求加速增长。 UCLA Health 2023 报告显示,医学界了解饮食科学和营养在慢性疾病进展中的作用。因此,减少钠摄入量以及尽量减少添加精制糖和饱和脂肪摄入等简单策略可以帮助预防饮食相关疾病并促进整体健康。这种营养成分通过生理盐水提供,包括盐(钠和钾)、糖(碳水化合物和葡萄糖)、植物和动物源饮食、健康饮水、咖啡和茶、果汁或苏打水等。
报告介绍了生理盐水市场的领先企业,包括 Fresenius Kabi AG、Merck KGaA、AdipoGen Life Sciences Inc、Enzo Life Sciences Inc、ICU Medical Inc、Grifols SA、Geno Technology Inc、B Braun Medical Inc、Pfizer Inc 和 Ward's Science。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Enzymatic DNA Synthesis Market
- Biopharmaceutical Tubing Market
- Smart Water Metering Market
- Electronic Signature Software Market
- Nitrogenous Fertilizer Market
- Adaptive Traffic Control System Market
- Virtual Production Market
- Grant Management Software Market
- Small Satellite Market
- Portable Power Station Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The physiological saline market majorly consists of the players such Fresenius Kabi AG, Merck KGaA, AdipoGen Life Sciences Inc, Enzo Life Sciences Inc, ICU Medical Inc, Grifols SA, Geno Technology Inc, B Braun Medical Inc, Pfizer Inc, and Ward's Science, and amongst others.
Global physiological saline market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the physiological saline market in 2022.
Fresenius Kabi AG and B Braun Medical Inc are the top two companies that hold huge market shares in the physiological saline market.
Physiological saline is a 0.9% sodium chloride (NaCl) solution referred to as "physiological" containing isotonic solution with an osmotic pressure equivalent to that of body fluids under normal conditions. To create physiological saline, people dissolve 9g of pure salt with 1 liter of distilled water. Currently, physiological saline has dosage forms such as bottles of solution for infusion, physiological saline eye drops, nose drops, and ear drops, usually available in the form of 100ml, 250ml, and 500ml.
The normal saline segment held the largest share of the market in the global physiological saline market in 2022.
The CAGR value of the physiological saline market during the forecasted period of 2022-2030 is 6.4%.
The intravenous (IV) segment dominated the global physiological saline market and held the largest market share in 2022.
Key factors that are driving the growth of this market are rising prevalence of serious illnesses and fluid electrolytes disorders and surging demand for fluid electrolytes in ageing population are expected to boost the market growth for the physiological saline over the years.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Physiological Saline Market
- Fresenius Kabi AG
- Merck KGaA
- AdipoGen Life Sciences Inc
- Enzo Life Sciences Inc
- ICU Medical Inc
- Grifols SA
- Geno Technology Inc
- B Braun Medical Inc
- Pfizer Inc
- Ward's Science
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.